Document Detail


I could lose everything: understanding the cost of a brain tumor.
MedLine Citation:
PMID:  17581698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although studies have quantified the costs of cancer treatment, few have evaluated the widespread impact of cancer costs on the family unit. Specifically, little is known regarding how cancer affects patients and their families financially, and how they cope with these costs. The purpose of this descriptive study was to explore the financial impact of cancer care in neuro-oncology. Content analysis was used to examine data from interviews with 20 adults receiving treatment for a primary malignant brain tumor. Participants were recruited from across the United States through an advertisement in a national support group newsletter. Four major themes were identified -"paying for medication/healthcare", "strategies to offset costs", "impact of cancer costs", and "fear/uncertainty". Within the major themes several sub-themes were also recognized. In the theme of paying for medication/healthcare, participants emphasized sub-themes such as frustrations over "not qualifying/red tape" and being "thankful" for what was covered. Some of the strategies used to offset cancer costs included "cashing in" and relying on "family/friends" for financial support. When describing the impact of cancer costs, participants mentioned sub-themes including the "cost to their family", the "cost of their disability", and the impact of a "change in income/job". Results elucidate the financial concerns and coping strategies of persons undergoing treatment for cancer. These data help target patients' support needs during treatment, such as providing for their family and navigating their insurance policies, and suggest more efficient implementation of financial interventions are needed to alleviate the emotional burden of cancer costs.
Authors:
Sarah Bradley; Paula R Sherwood; Heidi S Donovan; Rebekah Hamilton; Margaret Rosenzweig; Allison Hricik; Alyssa Newberry; Catherine Bender
Related Documents :
6722758 - Fragile sites and cancer breakpoints.
8472798 - Familial risk of colo-rectal cancer in a low incidence area in southern italy.
11075868 - Associations between family history of cancer and genes coding for metabolizing enzymes...
6735258 - Familial juvenile polyposis coli; increased risk of colorectal cancer.
8849298 - Paradoxical response to itraconazole treatment in a patient with onychomycosis caused b...
8252208 - Photodynamic therapy of squamous cell carcinoma. an evaluation of a new photosensitizin...
Publication Detail:
Type:  Journal Article     Date:  2007-06-21
Journal Detail:
Title:  Journal of neuro-oncology     Volume:  85     ISSN:  0167-594X     ISO Abbreviation:  J. Neurooncol.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-11-13     Completed Date:  2008-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309335     Medline TA:  J Neurooncol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  329-38     Citation Subset:  IM    
Affiliation:
School of Nursing, University of Pittsburgh, 336 Victoria Building, 3500 Victoria Street, Pittsburgh, PA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Agents / economics*,  therapeutic use
Astrocytoma / economics*,  psychology,  therapy
Brain Neoplasms / economics*,  psychology,  therapy
Comprehension
Cost of Illness*
Female
Glioblastoma / economics*,  psychology,  therapy
Humans
Male
Middle Aged
Self Assessment (Psychology)
Social Support
United States
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tissue transglutaminase in tumour progression: friend or foe?
Next Document:  Densin and beta-catenin form a complex and co-localize in cultured podocyte cell junctions.